![Eti Mitrany](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Eti Mitrany
Directeur/Bestuurslid bij BRAINSWAY LTD.
Vermogen: - $ op 31-05-2024
Actieve functies van Eti Mitrany
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
BRAINSWAY LTD. | Directeur/Bestuurslid | 05-06-2016 | - |
Independent Dir/Board Member | 05-06-2016 | - | |
Trioxnano Ltd. | Directeur/Bestuurslid | 01-01-2023 | - |
Loopbaan van Eti Mitrany
Eerdere bekende functies van Eti Mitrany
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
CytoReason Ltd.
![]() CytoReason Ltd. Information Technology ServicesTechnology Services CytoReason Ltd. is an Israeli company that aims to link mechanisms across diseases, treatments, and patient groups. The company is based in Tel Aviv-Yafo, Israel. The company provides a platform that connects decisions to the underlying science of drug programs. The company's team includes top immunologists, a chief medical officer, a chief data scientist, a VP of strategic alliances, a chief technology officer, and a head of commercial operations. The company focuses on immune-mediated diseases such as inflammatory bowel disease, atopic dermatitis, rheumatoid arthritis, and asthma, immuno-oncology diseases such as non-small cell lung cancer, renal cell carcinoma, and melanoma, and fibrosis diseases such as non-alcoholic steatohepatitis, systemic sclerosis, and idiopathic pulmonary fibrosis. CytoReason was founded in 2016 by Elina Starosvetsky, Ksenya Kveler, Yuval Kalugny, Renaud Gaujoux, David Harel, and Shai Shen-Orr. David Harel has been the CEO since 2016. | Financieel Directeur/CFO | 01-04-2021 | 01-12-2022 |
TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Officer/Principal | 01-01-1995 | 01-01-2020 |
Copaxone | Financieel Directeur/CFO | - | - |
Opleiding van Eti Mitrany
Tel-Aviv University | Undergraduate Degree |
Statistieken
Internationaal
Israël | 6 |
Verenigde Staten | 2 |
Operationeel
Director/Board Member | 2 |
Director of Finance/CFO | 2 |
Independent Dir/Board Member | 1 |
Sectoraal
Health Technology | 3 |
Consumer Services | 2 |
Technology Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Health Technology |
BRAINSWAY LTD. | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
Trioxnano Ltd. | |
CytoReason Ltd.
![]() CytoReason Ltd. Information Technology ServicesTechnology Services CytoReason Ltd. is an Israeli company that aims to link mechanisms across diseases, treatments, and patient groups. The company is based in Tel Aviv-Yafo, Israel. The company provides a platform that connects decisions to the underlying science of drug programs. The company's team includes top immunologists, a chief medical officer, a chief data scientist, a VP of strategic alliances, a chief technology officer, and a head of commercial operations. The company focuses on immune-mediated diseases such as inflammatory bowel disease, atopic dermatitis, rheumatoid arthritis, and asthma, immuno-oncology diseases such as non-small cell lung cancer, renal cell carcinoma, and melanoma, and fibrosis diseases such as non-alcoholic steatohepatitis, systemic sclerosis, and idiopathic pulmonary fibrosis. CytoReason was founded in 2016 by Elina Starosvetsky, Ksenya Kveler, Yuval Kalugny, Renaud Gaujoux, David Harel, and Shai Shen-Orr. David Harel has been the CEO since 2016. | Technology Services |
Copaxone |
- Beurs
- Insiders
- Eti Mitrany
- Ervaring